Natco Pharma Ltd - NATCO PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE987B01026
₹ 1,039.60 (-0.15%) icon21 Feb, 2024, 9:59:53 AM
Open
₹ 1,039.00
Prev. Close
₹ 1,041.15
Turnover(lac)
₹ 0.02
Day's High
₹ 1,049.00
Day's Low
₹ 1,029.25
52 Wk High
₹ 1,108.35
52 Wk Low
₹ 520.25
Book Value
₹ 315.94
Face Value
₹ 2.00
Mkt. Cap (Cr.)
₹ 18,620.26
P/E
15.36
EPS
67.65
Div. Yield
0.54

Natco Pharma Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 2/21/2024 9:59:53 AM

    ₹ 1039.6 -1.55 -0.15
  • Open
  • ₹ 1,039
  • Prev. Close
  • ₹ 1,041.15
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 1,049
  • Day's Low
  • ₹ 1,029.25
  • 52 Week's High
  • ₹ 1,108.35
  • 52 Week's Low
  • ₹ 520.25
  • Book Value
  • ₹ 315.94
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 18,620.26
  • P/E
  • 15.36
  • EPS
  • 67.65
  • Divi. Yield
  • 0.54

Natco Pharma Ltd Corporate Actions

02 Feb , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Feb , 2024

12:00 AM

14 Nov , 2023

12:00 AM

Dividend

Dividend amount: 1.25
Announcement date: 14 Nov , 2023

View Details

03 Nov , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Nov , 2023

12:00 AM

05 Sep , 2023

12:00 AM

AGM

Announcement date: 05 Sep , 2023

View Details

09 Aug , 2023

12:00 AM

Dividend

Dividend amount: 7
Announcement date: 09 Aug , 2023

View Details

31 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Jul , 2023

12:00 AM

19 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Mar , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

09 Feb , 2023

12:00 AM

Dividend

Dividend amount: 1.25
Announcement date: 09 Feb , 2023

View Details

05 Sep , 2023

12:00 AM

BookCloser

View Details

Natco Pharma Ltd News and Update

Image not found
  • 1 day ago |
  • 12:02 AM

The Bank Nifty surged by nearly 200 points to around 46,572 levels, led by gains in Bandhan Bank, ICICI Bank, and AU Small Finance Bank.

Image not found
Image not found
  • IIFL News Service |
  • 16 February, 2024 |
  • 11:57 PM
Image not found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Natco Pharma Ltd SHAREHOLDING SNAPSHOT
21 February , 2024 | 10:18 AM

PROMOTER - TOTAL49.71%

Indian: 49.71%

Foreign: 0%

NON-PROMOTER - TOTAL 50.29%

Institutions: 24.97%

Non-Institutions: 25.32%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Natco Pharma Ltd FINANCIALS

Natco Pharma Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Natco Pharma Ltd

  • V C Nannapaneni
  • Managing Director
  • G S Murthy
  • Chairman & Independent Directo
  • Rajeev Nannapaneni
  • Director & Chief Executive Off
  • T V Rao
  • Non-Exec. & Independent Dir.
  • D G Prasad
  • Non-Exec. & Independent Dir.
  • Leelaa Digumarti
  • Non-Exec. & Independent Dir.
  • PSRK Prasad
  • Vice President & Director
  • MUR Naidu
  • Non-Exec. & Independent Dir.
  • D Linga Rao
  • President & Director
  • Pavan Bhat
  • Vice President & Director
  • Venkat Ramesh
  • Company Sec. & Compli. Officer
  • A D Murthy Chavali
  • Independent Director

Summary

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs). The Companys focus is primarily on niche therapeutic areas and complex products. It sells products in over 40 countries. FDF products are sold in the United States, India, Europe and the rest of the world (RoW). Natcos API products are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets such as Brazil, Europe and USA. In the API segment, Natco has capabilities to develop and manufacture products with multi-step synthesis, semi synthetic fusion technologies, high-potency APIs and peptides.Natco Pharma is also engaged in contract manufacturing business, whereby the company undertakes selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products.Natco Pharma was originally incorporated on 19 September 1981 as private limited company under the name of Natco Fine Pharmaceuticals Private Limited. It became a deemed public company with effect from 1 July 1992. The name of the company was changed to Natco Pharma Limited and a fresh certificate of incorporation consequent upon change of name was issued by the RoC, Andhra Pradesh on 18 February 1993. The company was converted into a public limited company and a fresh certificate of incorporation... Read More


Reports by Natco Pharma Ltd


Reports by Natco Pharma Ltd

Company FAQ

No Record Found